Acura's abuse-deterrent pain drug fails mid-stage study goal

(Reuters) - Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing likability among abusers, sending its shares down 34 percent in after-hours trading. The study showed that Acura's tablet, Aversion H&A, had a slighter lower measure of liking when compared with the generic hydrocodone/acetaminophen tablet. The tablet was tested for potential abuse by snorting. The company said it expects the submission of a marketing approval application to be delayed. (Reporting By Vrinda Manocha in Bangalore)



via Health News Headlines - Yahoo! News http://news.yahoo.com/acuras-abuse-deterrent-pain-drug-fails-mid-stage-204235925.html